The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Cooper Jeffrey H since year 2005.
The trader's CIK number is 1301173.
At the time of this reporting, Cooper Jeffrey H is the SVP, Chief Financial Officer of Biomarin Pharmaceutical Inc .
(stock ticker symbol BMRN).
See this page for all insider trading activities at Biomarin Pharmaceutical Inc .
Stock purchases, sales, and option exercises reported by insider Cooper Jeffrey H since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2008-04-30
BMRN
Biomarin Pharmaceutical Inc
Purchase
1,070
13.95
14,925
2008-02-29
BMRN
Biomarin Pharmaceutical Inc
Option Exercise
55,625
7.78
432,540
2008-02-29
BMRN
Biomarin Pharmaceutical Inc
Sale
49,720
37.66
1,872,594
2008-02-29
BMRN
Biomarin Pharmaceutical Inc
Sale
5,905
37.95
224,088
2007-10-08
BMRN
Biomarin Pharmaceutical Inc
Option Exercise
12,380
8.10
100,278
2007-10-08
BMRN
Biomarin Pharmaceutical Inc
Sale
12,380
26.00
321,880
2007-09-26
BMRN
Biomarin Pharmaceutical Inc
Sale
12,500
24.50
306,250
2007-09-26
BMRN
Biomarin Pharmaceutical Inc
Option Exercise
12,500
8.10
101,250
2007-09-06
BMRN
Biomarin Pharmaceutical Inc
Option Exercise
13,536
8.10
109,641
2007-09-06
BMRN
Biomarin Pharmaceutical Inc
Sale
13,536
22.50
304,560
2007-08-17
BMRN
Biomarin Pharmaceutical Inc
Option Exercise
20,000
6.35
126,933
2007-08-17
BMRN
Biomarin Pharmaceutical Inc
Sale
20,000
20.28
405,658
2007-08-08
BMRN
Biomarin Pharmaceutical Inc
Option Exercise
12,500
8.10
101,250
2007-08-08
BMRN
Biomarin Pharmaceutical Inc
Sale
12,500
21.00
262,500
2006-12-06
BMRN
Biomarin Pharmaceutical Inc
Option Exercise
14,500
8.10
117,450
2006-12-06
BMRN
Biomarin Pharmaceutical Inc
Sale
14,500
18.00
261,000
2006-08-29
BMRN
Biomarin Pharmaceutical Inc
Option Exercise
26,000
7.12
184,990
2006-08-29
BMRN
Biomarin Pharmaceutical Inc
Sale
26,000
16.00
416,000
2006-03-16
BMRN
Biomarin Pharmaceutical Inc
Option Exercise
12,500
8.10
101,250
2006-03-16
BMRN
Biomarin Pharmaceutical Inc
Sale
12,500
14.85
185,625
2006-03-01
BMRN
Biomarin Pharmaceutical Inc
Option Exercise
15,500
5.64
87,420
2006-03-01
BMRN
Biomarin Pharmaceutical Inc
Sale
15,500
13.25
205,375
2006-02-27
BMRN
Biomarin Pharmaceutical Inc
Option Exercise
1,000
5.15
5,150
2006-02-27
BMRN
Biomarin Pharmaceutical Inc
Sale
1,000
13.25
13,250
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Cooper Jeffrey H
(SVP, Chief Financial Officer of Biomarin Pharmaceutical Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
